Money Lancer
← Equity: Sectoral-Pharma and Healthcare
Tata Mutual Fund
Tata Mutual Fund · Equity: Sectoral-Pharma and Healthcare

Tata India Pharma & Healthcare Fund-Regular Plan-Growth

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

EquityBenchmark · NIFTY Pharma TRITER · 2.37%Inception · 28-12-2015
NAV
₹31.28
-0.37% · as of 14-10-2026
Since inception
11.10%
CAGR
Benchmark (inception)
14.41%
CAGR
Fund size
₹1,511 Cr
AUM
Expense ratio
2.37%
29-09-2026
Performance

Returns vs benchmark & category

Since inception: +11.10% CAGR vs benchmark +14.41%.

Portfolio

Where the money is invested

Top holdings

SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-8.51%
MAX HEALTHCARE INSTITUTE LIMITED EQ5.68%
HEALTHCARE GLOBAL ENTERPRISES LTD EQ5.52%
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-5.12%
ABBOTT INDIA LIMITED EQ4.97%
CIPLA LIMITED EQ NEW FV RS.2/-4.77%
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-4.61%
RAINBOW CHILDRENS MEDICARE LIMITED EQ4.42%
Dr. Reddys Laboratories Ltd4.26%
GLAXOSMITHKLINE PHARMACEUTICALS LTD EQ4.12%

Sector allocation

Healthcare92.02%
Chemicals4.17%
Fast Moving Consumer Goods1.23%
Riskometer
LowVery High
Very High

What if you'd SIP'd here?

@ 11.1% p.a.
₹10,000
10 years
Projected value
₹22,02,801
Invested: ₹12,00,000
Gained: ₹10,02,801
Start this SIP →

Illustration based on fund's since-inception return. Past performance is not indicative of future returns.

Risk Analysis

How this fund manages risk

Fund manager
R
Rajat Srivastava
Manager since fund inception data not available
ISIN & identifiers
AMFI code
135812
ISIN (Growth)
INF277K016A9
ISIN (Div Re-inv)
—
Status
Open Ended Schemes
Peers

Other Equity: Sectoral-Pharma and Healthcare funds

Want a personalised recommendation?

Our team will tell you whether this fund fits your goals, allocation and risk profile — and suggest peers if it doesn't.

Chat with us